首页> 外文期刊>Breast cancer research and treatment. >Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
【24h】

Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?

机译:立体定向大芯针穿刺活检对BI-RADS 5病变的手术治疗有益吗?

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Due to screening mammography, more nonpalpable mammographic lesions warrant histological evaluation. Stereotactic large-core needle biopsy (SLCNB) has been shown to be as effective in diagnosing these lesions as diagnostic surgical excision, and has become the preferred diagnostic procedure for most mammographic lesions. Since radiologically malignant BI-RADS 5 lesions are almost always carcinoma, some centers advocate prompt diagnostic surgical excision for these lesions instead of SLCNB. For some patients this diagnostic surgical intervention may serve as definitive treatment. We set out to find a subgroup of mammographic BI-RADS 5 lesions for which surgical biopsy might be preferable. METHODS: Of 1644 consecutive nonpalpable lesions referred for SLCNB between April 1997 and May 2002, 238 were classified as BI-RADS 5. We assessed the number of carcinomas and the surgical interventions performed. Outcomes were compared between various types of mammographic lesions: density with calcifications, density without calcifications, and calcifications only. Different theoretical strategies for diagnostic work-up of BI-RADS 5 lesions were explored. RESULTS: Carcinoma was found in 229/238 lesions (96%). Most mammographic densities were invasive cancer (97%), while calcifications only showed the highest risk for DCIS (51%). In our study (current practice) all lesions were scheduled to first undergo SLCNB. A scenario was proposed where all lesions with only a density would be scheduled directly for sentinel node biopsy (SNB) and tumour excision (n = 154; 65%), while other lesions would still be scheduled for SLCNB. When we compared this scenario to current practice, four out of 238 patients (< 2%) would be 'overtreated' with SNB. CONCLUSIONS: Our findings confirm a high predictive value of malignancy for BI-RADS 5 lesions (96%). Surgical excision is therefore imperative for all BI-RADS 5 lesions, irrespective of SLCNB results. For BI-RADS 5 lesions presenting as mammographic densities only, we propose to consider surgical excision with SNB to be the first diagnostic and therapeutic procedure. SLCNB is preferred in all other cases.
机译:简介:由于乳腺X线摄影筛查,更多不可触及的乳腺X线摄影病灶需要组织学评估。立体定向大芯针穿刺活检(SLCNB)已被证明与诊断性手术切除一样有效地诊断这些病变,并且已成为大多数乳腺X线摄影病变的首选诊断方法。由于放射性恶性BI-RADS 5病变几乎总是癌变,因此一些中心主张对这些病变而不是SLCNB进行及时的诊断性手术切除。对于某些患者,这种诊断性手术干预可以作为确定性治疗。我们着手寻找乳腺X线摄影BI-RADS 5病变的亚组,对于这些亚组,手术活检可能更可取。方法:在1997年4月至2002年5月间连续1644例因SLCNB转诊的不可触及病变中,有238例被归类为BI-RADS5。我们评估了癌的数量和所进行的手术干预。比较了各种类型的乳腺钼靶病变的结果:有钙化的密度,无钙化的密度和仅钙化。探索了BI-RADS 5病变诊断诊断的不同理论策略。结果:在229/238个病灶中发现了癌(96%)。乳房X光检查的大多数密度是浸润性癌(97%),而钙化仅显示出DCIS的最高风险(51%)。在我们的研究(当前实践)中,所有病变均计划首先接受SLCNB。提出了一种方案,其中所有仅具有密度的病变将被直接安排用于前哨淋巴结活检(SNB)和肿瘤切除(n = 154; 65%),而其他病变仍将安排进行SLCNB。当我们将这种情况与当前实践进行比较时,将有238名患者中有4名(<2%)被SNB“过度治疗”。结论:我们的发现证实了BI-RADS 5病变的恶性预测价值较高(96%)。因此,无论SLCNB结果如何,所有BI-RADS 5病变均必须手术切除。对于仅表现为乳腺X线密度的BI-RADS 5病变,我们建议将SNB手术切除作为第一个诊断和治疗程序。在所有其他情况下,SLCNB是首选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号